Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IES: Exemestane vs Tamoxifen Switch in Breast Cancer
NCT00038467Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 1998
- Primary completion
- Jun 2003
- Modality
- Small Molecules
- Countries
- 37
01
Overview
A Phase 3 trial of exemestane in breast cancer, sponsored by Pfizer. Started Feb 1998; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00038467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038467.